These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15878482)

  • 1. Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae.
    Cazzola M; Salzillo A; De Giglio C; Piccolo A; Califano C; Noschese P
    Respir Med; 2005 Jun; 99(6):663-9. PubMed ID: 15878482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
    Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
    Block SL; Cifaldi M; Gu Y; Paris MM
    Clin Ther; 2005 Jun; 27(6):786-94. PubMed ID: 16117986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
    Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.
    Pasqua F; Biscione G; Crigna G; Cazzola M
    Ther Adv Respir Dis; 2008 Aug; 2(4):209-14. PubMed ID: 19124373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
    Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of clinical effectiveness and direct costs of azithromycin treatment for exacerbation of chronic obstructive pulmonary disease in hospitalized patients and ambulatory care].
    Faber M; Jahnz-Rózyk K; Kucharczyk A; Targowski T; From S; Mamełka B
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():96-9. PubMed ID: 15524029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
    J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and tolerance of azithromycin in respiratory tract infections in children].
    Toscano MA; Marzullo E; Minneci MS; Salmeri M; Chinnici V; Emanuele A; Gulino A; Malafarina D; Mannino G; Marletta V
    Minerva Pediatr; 1995 Jun; 47(6):249-60. PubMed ID: 7476752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease].
    Targowski T; Jahnz-Rózyk K
    Pol Merkur Lekarski; 2010 Apr; 28(166):311-4. PubMed ID: 20491344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose azithromycin for the treatment of children with acute otitis media.
    Soley CA; Arguedas A
    Expert Rev Anti Infect Ther; 2005 Oct; 3(5):707-17. PubMed ID: 16207162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model.
    Canut A; Martín-Herrero JE; Labora A; Maortua H
    J Antimicrob Chemother; 2007 Sep; 60(3):605-12. PubMed ID: 17595285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
    Sethi S; Evans N; Grant BJ; Murphy TF
    N Engl J Med; 2002 Aug; 347(7):465-71. PubMed ID: 12181400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease.
    Chelidze K; Jgarkava M
    Georgian Med News; 2008 Jun; (159):27-30. PubMed ID: 18633147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.
    Milstone A; Patsimas J; Farzan D; Castaldo R; Singh H; Feurer I; Harnett J; Luke DR;
    Clin Ther; 2005 Jun; 27(6):926-39. PubMed ID: 16117993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial flora in acute exacerbations of chronic obstructive pulmonary disease (COPD) in Kunming, China].
    Yang X; Strobel M; Tian L; Barennes H; Buisson Y
    Med Mal Infect; 2011 Apr; 41(4):186-91. PubMed ID: 21195565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the relationship between airway bacterial infections and acute exacerbations in patients with chronic obstructive pulmonary disease].
    Zhou YQ; Xie CM; Chen DM; Chen L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 May; 28(5):503-6. PubMed ID: 17877185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.